UR238

Overview

UR238 is a proteasome inhibitor. UR238 reduces levels of the immunomodulator HE4 . UR238 decreases PDL1 expression on cells. UR238 exhibits anticancer activity against epithelial ovarian cancer .

Application

Products | Products > Disease Areas > Epithelial Ovarian Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Proteasome | Products > Signaling Pathways > PD-1/PD-L1

Product Information

• Catalog No.: HY-180127
• CAS No.: 2728747-80-4
• Molecular Formula: C40H58N6O8S
• Molecular Weight: 782.99
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source